Product Center
Ab&B Bio-Tech Co., Ltd. JS Innovation Vaccine Project Is Underway!
- Categories:Company news
- Author:
- Origin:
- Time of issue:2022-03-02
- Views:
(Summary description)New Year with New Atmosphere, Embark on a New Journey! We have laid the foundation! The Chinese New Year Begins Brightly
Ab&B Bio-Tech Co., Ltd. JS Innovation Vaccine Project Is Underway!
(Summary description)New Year with New Atmosphere, Embark on a New Journey!
We have laid the foundation!
The Chinese New Year Begins Brightly
- Categories:Company news
- Author:
- Origin:
- Time of issue:2022-03-02 16:15
- Views:
We have laid the foundation!
The Chinese New Year Begins Brightly
Sun Hongjian, Director of the Management Committee of the Medical High-tech Zone, Mayor of Gaogang District, and Secretary of the Party Working Committee of the Medical Park, expressed his earnest hopes and requirements for the innovative vaccine project that is about to fill the international gap in his speech: "Implement it quickly and achieve production results!" Providing important support in the process of building a "domestic first, world-famous" pharmaceutical city in China.
The Chairman and General Manager of the company, An Youcai, warmly welcomed all the leaders and guests present, and expressed sincere gratitude to all the people from all walks of life who have supported the company for many years! He emphasized that Zhonghui Yuantong will make every effort, work hard and never stop, and demonstrate its corporate responsibility and make due contributions in the process of building a national vaccine industry cluster highland in China Pharmaceutical City and enhancing the core competitiveness of the park's vaccine industry!
The industrialization project of the new influenza vaccine is one of the major projects in Jiangsu Province in 2022, with a total investment of 2 billion yuan. It is based on a high-level independent innovation of a new drug, the quadrivalent influenza virus subunit vaccine. In response to the call of the country to promote international cooperation in vaccines, it aims to build a world-class intelligent factory that meets international standards from a high starting point, and quickly achieve the industrialization of multiple innovative vaccine varieties!Relevant information
-
The Launch Meeting of Phase I/II Clinical Trial for Recombinant Herpes Zoster Vaccine (CHO Cell) was successfully heldRecently, the Phase I/II clinical trial launch meeting for the recombinant herpes zoster vaccine (CHO cell), co-developed by Ab&B Bio-Tech CO., LTD. JS. and Yither Biotech (Shanghai) Co., Ltd., was successfully held in Henan, and the first-in-human (FIH) dosing was successfully completed. - Ab&B Bio and Yither Bio Have Both Obtained Qualification Certification! 12-30
- Kickoff Meeting for Clinical Research on Quadrivalent Influenza Virus Subunit Vaccine in Children with Nephrotic Syndrome Successfully Held 12-25
- IND Application for Influenza Virus Subunit Vaccine (Adjuvanted) Approved 10-30
- The Application for the Marketing of Trivalent Influenza Virus Subunit Vaccine has been Accepted! 10-08
Got a project? Contact us today !
At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.
Contact
E-mail:haixin.zhang@yitherbiotech.com
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
